Dianthus Therapeutics (DNTH) EBIT Growth (1y) (2018 - 2025)
Dianthus Therapeutics (DNTH) EBIT Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 2,150.96% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 183.45% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Dianthus Therapeutics | 3.92 Bn | 3.51 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -34.74% |
| Jun 30, 2025 | -57.30% |
| Mar 31, 2025 | -85.93% |
| Dec 31, 2024 | -146.34% |
| Sep 30, 2024 | -89.73% |
| Jun 30, 2024 | -88.55% |
| Mar 31, 2024 | -132.25% |
| Dec 31, 2023 | -21.16% |
| Sep 30, 2023 | -90.93% |
| Jun 30, 2023 | 34.88% |
| Mar 31, 2023 | 67.76% |
| Dec 31, 2022 | 46.91% |
| Sep 30, 2022 | 54.76% |
| Jun 30, 2022 | -2.69% |
| Mar 31, 2022 | -27.47% |
| Dec 31, 2021 | -5.64% |
| Sep 30, 2021 | 0.74% |
| Jun 30, 2021 | 12.00% |
| Mar 31, 2021 | 11.99% |
| Dec 31, 2020 | 22.62% |